|
|
- 2016
涎腺导管癌10例临床分析
|
Abstract:
摘要 目的: 分析涎腺导管癌的临床特点以及治疗效果。方法: 回顾分析2007年10月~2014年11月经术后病理确诊且完成随访患者的临床资料。结果: 10例患者中,男性8例,女性2例,年龄46~89岁,平均(64.7±12.7)岁。8例累及腮腺,2例累及颌下腺。临床表现为腮腺区或颌下区肿物,可伴有近期突然增大,局部神经侵犯症状。影像学发现局部占位性病变,边界多为不清,不均匀强化。10例患者均行手术治疗,术后6例予以放疗,4例未放疗。随访至术后7~97个月,中位无病生存时间为37.5个月。10人均随访满1年,其中1例复发,1年无病生存率为90%(95%CI:55-100),8人随访满3年,其中3人复发,3年无病生存率为62.5%(95%CI:24-91),7人随访满5年,其中3人复发,5年无病生存率为57.1%(95%CI:18-90)。结论: 涎腺导管癌较罕见,临床表现及辅助检查无明显特异性,确诊主要依靠病理结果。该疾病预后较差,手术治疗为首选方法,术后需联合放疗。生物靶向治疗有望成为新的辅助治疗方式之一
| [1] | Sartorius C, Gille F, Bédrossian-Pfingsten J, et al. Salivary duct carcinoma of the sublingual gland-a case report [J]. Laryngorhinootologie,2006,85(3)∶517-519 |
| [2] | 江明祥,邵国良,孙晶晶,等.涎腺导管癌的 CT 和 MR 表现[J].中华放射学杂志,2014,48(7)∶906-909 |
| [3] | 俞光岩, 吴奇光.11例涎派导管癌临床病理分析[J].中华口腔医学杂志,1993,28(1)∶134-136 |
| [4] | Hosal AS, Fan C, Barnes L, et al. Salivary duct carcinoma [J]. Otolaryngology--Head and Neck Surgery,2003,129(5)∶720-725 |
| [5] | Huh KH, Heo MS, Lee SS, et al. Three new cases of salivary duct carcinoma in the palate: a radiological diagnosis and review of the literature [J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod,2003,95(4)∶752-760 |
| [6] | Zbaren P, Zbaren S, Caversaccio MD, et al. Carcinoma expleomorphic adenoma: diagnostic difficulty and outcome [J]. Otolaryngol Head Neck Surg,2008,138(4)∶601-606 |
| [7] | Limaye SA, Posner MR, Krane JF, et al. Trastuzumab for the treatment of salivary duct carcinoma [J]. The oncologist, 2013,18(2)∶294-300 |
| [8] | Jaspers HC, Verbist BM, Schoffelen R, et al. Androgen receptor-positive salivary duct carcinoma: a disease entity with promising new treatment options [J]. J Clin Oncol, 2011, 29∶e473-476 |
| [9] | Campos-Gmez S, Flores-Arredondo JH, Dorantes-Heredia R, et al. Case report: anti-hormonal therapy in the treatment of ductal carcinoma of the parotid gland [J]. BMC Cancer,2014,14(4)∶701-705 |
| [10] | Jaehne M, Roeser K, Jaekel T, et al. Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases [J]. Cancer,2005,103(9)∶2526-2533 |
| [11] | Lewis JE, Olsen KD, Sebo TJ. Carcinoma ex-pleomorphic adenoma: pathologic analysis of 73 cases [J]. Hum Pathol,2001,32(3)∶596-604 |
| [12] | Olsen KD, Lewis JE. Carcinoma ex-pleomorphic adenoma: a clinicopathologic review [J]. Head Neck,2001,23(4)∶705-712 |
| [13] | Wee DT, Thomas AA, Bradley PJ. Salivary duct carcinoma: what is already known, and can we improve survival [J]. J Laryngol Otol, 2012, 126(1)∶S2-7 |
| [14] | 魏松锋,运新伟,李亦工,等.涎腺导管癌临床生物学特点及预后分析[J].中华普通外科杂志,2010,25(3)∶540-542 |
| [15] | 卫英,江明祥,邵国良,等.涎腺导管癌的 CT, MR 表现与病理对照分析[J].影像诊断与介入放射学,2015,24(2)∶267-271 |
| [16] | Simpson RHW, Desai S, Di Palma S. Salivary duct carcinoma in situ of the parotid gland [J]. Histopathology,2008,53(3)∶416-425 |
